tiprankstipranks
MyMD Pharmaceuticals (GB:0A8D)
LSE:0A8D

MyMD Pharmaceuticals (0A8D) Share Price & Analysis

0 Followers

0A8D Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.38 - $68.76
Previous Close$2.4
Volume204.00
Average Volume (3M)452.00
Market Cap
$4.92M
Enterprise Value-$3.48M
Total Cash (Recent Filing)$8.47M
Total Debt (Recent Filing)$72.63K
Price to Earnings (P/E)N/A
Beta1.07
May 20, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,091,638
10 Day Avg. Volume190
30 Day Avg. Volume452
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.99
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

0A8D FAQ

What was MyMD Pharmaceuticals’s price range in the past 12 months?
MyMD Pharmaceuticals lowest share price was $2.38 and its highest was $68.76 in the past 12 months.
    What is MyMD Pharmaceuticals’s market cap?
    Currently, no data Available
    When is MyMD Pharmaceuticals’s upcoming earnings report date?
    MyMD Pharmaceuticals’s upcoming earnings report date is May 20, 2019 which is 1775 days ago.
      How were MyMD Pharmaceuticals’s earnings last quarter?
      MyMD Pharmaceuticals released its earnings results on Apr 01, 2019. The company reported -$3.526 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.526.
        Is MyMD Pharmaceuticals overvalued?
        According to Wall Street analysts MyMD Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MyMD Pharmaceuticals pay dividends?
          MyMD Pharmaceuticals does not currently pay dividends.
          What is MyMD Pharmaceuticals’s EPS estimate?
          MyMD Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does MyMD Pharmaceuticals have?
          MyMD Pharmaceuticals has 2,091,638 shares outstanding.
            What happened to MyMD Pharmaceuticals’s price movement after its last earnings report?
            MyMD Pharmaceuticals reported an EPS of -$3.526 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of MyMD Pharmaceuticals?
              Currently, no hedge funds are holding shares in GB:0A8D
              ---

              MyMD Pharmaceuticals Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -94.97%
              12-Months-Change

              Fundamentals

              Return on Equity
              -31.26%
              Trailing 12-Months
              Asset Growth
              7.88%
              Trailing 12-Months

              Company Description

              MyMD Pharmaceuticals

              Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Akari Therapeutics
              BioCryst
              Cytokinetics
              Xenon
              MyMD Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis